Answers are grounded in this paper and cite their sources.
Demonstrates ginsenoside Rg1’s ability to restore neurogenesis in neural stem cells under simulated microgravity, indicating its potential for astronaut health support.
Microgravity-induced neural dysfunction poses a critical risk during long-term spaceflight. However, the intrinsic mechanosensing mechanisms by which neural stem cells (NSCs) decode gravitational loss into biochemical responses and effective multi-target countermeasures remain elusive. This study aims to clarify the protective mechanism of ginsenoside Rg 1 (Rg 1 ) on simulated microgravity (SMG)-damaged C17.2 mouse neural stem cells (NSCs) by targeting vimentin serine 56 (Ser56) phosphorylation and the mitogen-activated protein kinase (MAPK)/protein kinase B (AKT) signaling network, and verify its “multi-pathway synergy” characteristic guided by traditional Chinese medicine (TCM) theory. An SMG environment was established using a random positioning machine (RPM). The safe and effective concentration of Rg 1 (40 μmol/L) was screened using the cell counting kit-8 (CCK-8) assay. Mitochondrial function and cytoskeletal structure were evaluated via transmission electron microscopy and F-actin staining. Flow cytometry, Western blotting, quantitative real-time polymerase chain reaction, combined with global proteomics, phosphoproteomics, and extracellular signal-regulated kinase 1/2 (ERK1/2) inhibitor experiments, were employed to dissect the action mechanism of Rg 1 . First, SMG inhibited NSC differentiation, disrupted cytoskeletal structure, and induced apoptosis, with the core mechanism being the impairment of cytoskeletal architecture and its dynamic phosphorylation network. Second, 40 μmol/L Rg 1 restored F-actin continuity, rescued neurodifferentiation function, and inhibited apoptosis; these effects relied on the activation of the MAPK/AKT kinase network and the specific rescue of vimentin Ser56 phosphorylation. Third, Rg 1 regulated the kinase-intermediate filament (IF) axis through “ERK1/2-dependent and independent” dual pathways rather than single-target intervention. Notably, its regulatory effect directly acted on post-translational modification (phosphorylation) instead of merely altering protein abundance. Rg 1 restores cytoskeletal integrity and neurogenesis in C17.2 NSCs under SMG by regulating the kinase-IF axis. This modern molecular evidence bridges TCM theory with mechanobiology, confirming Rg 1 as a promising TCM candidate for protecting astronaut brain health. It exemplifies the “holistic regulation” of TCM and provides a paradigm for the application of TCM in space medicine.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: